Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people moving to 5mg Mounjaro notice a stronger reduction in appetite within the first one to two weeks of their new dose, though meaningful weight changes typically build over four to eight weeks. At 5mg, tirzepatide is working at a genuinely therapeutic level — unlike the 2.5mg starter pen, which exists mainly to let your body adjust. These are prescription-only medicines; a GPhC-registered prescriber assesses whether a dose increase is clinically right for you before it is dispensed. The timeline below is based on how the medicine behaves pharmacologically and on evidence from the SURMOUNT clinical programme, as summarised by the NHS tirzepatide medicines page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both the GIP and GLP-1 receptors involved in appetite regulation and gastric emptying. At 5mg, that dual action is fully in play. The most common early signal is a noticeably smaller appetite, meals feel satisfying sooner, and the background urge to snack tends to quieten. Some people also notice food smells and cravings feel less compelling than usual.
Nausea, queasiness or mild stomach discomfort can accompany the first one to two weeks on any new Mounjaro dose. This is the same pattern that applied at 2.5mg, just potentially a little stronger. For most people it settles within a fortnight. If you want a reminder of what the 2.5mg starting phase felt like by comparison, our page on how long 2.5mg Mounjaro takes to work covers that ground in detail.
Fatigue and mild headache in the first week or two are also reported, usually resolving as the body adjusts. These are listed among the known side effects on the NHS tirzepatide information page and in the Patient Information Leaflet. Severe or persistent stomach pain that spreads to the back is different, that warrants prompt medical attention, not waiting to see if it passes.
Tirzepatide has a half-life of roughly five days, so it takes four to five consecutive weekly injections to reach a stable concentration in the bloodstream. That steady state typically arrives around weeks four to five of your 5mg pen. Before that point, levels are still climbing dose to dose, and the appetite-suppressing effect is building rather than fully established.
Weight loss on the scales lags behind because a calorie deficit needs time to produce measurable fat loss. Even if appetite drops substantially from week one, the body needs several weeks to translate that reduced intake into a number that shows up meaningfully on a scale. Expecting visible scale movement in week two is setting the bar in the wrong place. Weeks four to eight is a more realistic window for most people to see a clear trend.
Hydration, protein intake and keeping active all influence how that deficit converts to weight change. Our Mounjaro 5mg overview covers practical considerations for this dose alongside the clinical context. And if you are curious about how 5mg compares to earlier results at 2.5mg, the does 5mg Mounjaro work page addresses that directly.
No. The SURMOUNT-1 trial, which involved 2,539 adults over 72 weeks, produced an average weight reduction of around 20–21% at the maximum 15mg dose, but averages conceal real spread. At 5mg specifically, individual response varies considerably. Starting weight, age, baseline metabolic rate, how closely someone can follow a reduced-calorie diet, and how active they are all shape the rate of change. Genetics and gut hormone sensitivity differ person to person too.
Some people find 5mg produces strong results over several months and choose to remain at this dose with their prescriber's agreement. Others progress through the titration schedule toward higher doses, particularly if the clinical review at their repeat order suggests room for greater effect. If you are wondering whether the earlier 2.5mg dose was doing enough before you stepped up, our page on whether 2.5mg Mounjaro is effective explores that question in detail. You can read more about the broader treatment context on the Mounjaro treatment page.
One practical timing point worth raising: if your pen is due around a bank holiday weekend, a Monday order after payday, or just before you travel, build that into your plan. A missed week does affect the steady-state concentration and can reset how settled your stomach feels on the next injection. Your prescriber is the right person to advise on gaps, the Patient Information Leaflet covers missed-dose guidance too.
Six weeks on 5mg with little apparent change is worth discussing with a prescriber rather than concluding the medicine doesn't work. A few things are worth ruling out: are the injections being stored correctly (refrigerated at 2–8°C per the leaflet)? Is the technique consistent, rotating sites between the abdomen, thigh and upper arm? Is diet genuinely reduced, or has appetite suppression led to different food choices rather than fewer calories overall?
If those factors are in order and appetite suppression still feels minimal, a prescriber may consider whether progressing to 7.5mg is appropriate, based on your full clinical picture. That decision requires a clinical review, it is not automatic. For people considering whether private treatment is the right route for them, our weight-loss treatment consultation page explains what the assessment involves.
On the question of cost at this dose, the how to get Mounjaro online page covers the access process and what a legitimate private prescription includes. Pricing context for tirzepatide more broadly sits on the weight-loss treatments overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.